StreetAlpha
13F holdings · Q3 2026

First Turn Management

Del Mar, CA · files as First Turn Management, LLC
Know the moment First Turn Management filesYou follow First Turn Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1993440

First Turn Management reported 38 stocks worth $753M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ELVN (5.8%), GH (5.2%) and ABVX (5.1%). Compared with Q2 2026, the fund opened new positions in GH, CRL and RGEN, added to ELVN, INBX and NAMS, trimmed ABVX, ROIV and UTHR and sold out of MIRM, SRRK and ORKA.

Latest filing: what First Turn Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
13 new5 added19 trimmed6 sold outBought about $217M · sold about $304M
New 13
See all 13 →
Added 5
Trimmed 19
See all 19 →
Sold out 6
See all 6 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$753M−19.4% vs last quarter
Stocks held3813 new · 6 sold out
Top 5 weight25.2%spread out
Turnover69%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
ELVN
Enliven Therapeutics Inc
$43.9M5.8%959K+4,340 (+0%)7 of 8
2
GH
Guardant Health Inc
$39.1M5.2%219KNew position4 of 8
3
ABVX
Abivax SA
$38.1M5.1%385K−105K (−21%)5 of 8
4
ROIV
Roivant Sciences Ltd
$36M4.8%986K−345K (−26%)5 of 8
5
UTHR
United Therapeutics Corp Del
$32.5M4.3%60K−25K (−29%)5 of 8
6
VRDN
Viridian Therapeutics Inc
$31.4M4.2%1.5M−145K (−9%)4 of 8
7
AXSM
Axsome Therapeutics Inc
$29.9M4.0%162K−56K (−26%)8 of 8
8
INSM
Insmed Inc
$28M3.7%246K−18K (−7%)8 of 8
9
CELC
Celcuity Inc
$26.2M3.5%329KNo change3 of 8
10
CRL
Charles Riv Labs Intl Inc
$25.6M3.4%87KNew position1 of 8
🔒 28 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
MIRM
Mirum Pharmaceuticals Inc
$25.5M218K
APOGEE THERAPEUTICS INC
$18.4M139K
SRRK
Scholar Rock Hldg Corp
$14.9M271K
ORKA
Oruka Therapeutics Inc
$14.8M155K
SION
Sionna Therapeutics Inc
$4.9M110K

🔒 Free account: see all 6.

Reported value

last 8 quarters
$558MQ4 '24
$496MQ1 '25
$536MQ2 '25
$666MQ3 '25
$875MQ4 '25
$895MQ1 '26
$935MQ2 '26
$753MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

First Turn Management 13F FAQ

What does First Turn Management own?

First Turn Management reported 38 stocks worth $753M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ELVN (5.8%), GH (5.2%) and ABVX (5.1%). The table above lists every position in the filing (the top 10 without an account).

What did First Turn Management buy and sell in Q3 2026?

Compared with Q2 2026: 13 new positions, 5 added to, 19 trimmed and 6 sold out. New positions include GH, CRL and RGEN. It sold all of MIRM, SRRK and ORKA.

When will First Turn Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is First Turn Management's portfolio worth?

The Q3 2026 filing reports $753M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.